B O O K - American College of Rheumatology

ACR/ARHP Poster Session B
810. Over-Reporting Is a Central Determinant of Pain and Symptom
Reporting in Fibromyalgia. Frederick Wolfe, National Data Bank
for Rheumatic Diseases, Wichita, KS.
811. Proteomic Mass Spectra Classification in Fibromyalgic Patients.
Camillo Giacomelli 3 , Laura Bazzichi 3 , Federica Ciregia 2 , Chiara
Baldini 3 , Francesca Sernissi 2 , Pasquale Pepe 1 , Laura Giusti 2 ,
Antonio Lucacchini 2 and Stefano Bombardieri 3 , 1 Department
of Clinical Pharmacology, University of Pisa, Pisa, Italy,
2
Department of Psychiatry, Neurobiology, Pharmacology and
Biotechnology. University of Pisa, Pisa, Italy, 3 Rheumatology
Unit. Department of Internal Medicine. University of Pisa, Pisa,
Italy.
812. Sexual Dysfunction in Female Fibromyalgia Patients. Jacob N.
Ablin 4 , Inna Gurevitz 3 , Hagit Cohen 1 and Dan Buskila 2 , 1 Ben-
Gurion University of the Negev, Beer Sheva, Israel, 2 Soroka
Medical Center, Beer Sheva, Israel, 3 Soroka Medical Center, Beer
- Sheva, Israel, 4 Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
813. Simplifying Fibromyalgia Assessment: The VASFIQ Brief
Symptom Scale. Chad S. Boomershine, Gergana Zlateva,
Yi Wang, Ed Whalen and Birol Emir, Vanderbilt University,
Nashville, TN.
814. Sodium Oxybate Improves Pain, Function, and PGIC in Patients
with Fibromyalgia: A Pooled Analysis of 2 Pivotal Clinical
Trials. I. Jon Russell 5 , Robert M. Bennett 3 , Cayetano Alegre 1 ,
John B. Winfield 4 , Chinglin Lai 2 , Y. Grace Wang 2 and Beverly
Benson 2 , 1 Hospital de la Vall d’Hebron, Alella, Spain, 2 Jazz
Pharmaceuticals, Inc., 3 Oregon Health & Science University,
Portland, OR, 4 University of North Carolina, Chapel Hill, NC,
5
University of Texas Health Science Center, San Antonio, TX.
815. Sodium Oxybate Improves Sleep and Fatigue in Patients with
Fibromyalgia: Pooled Analysis from 2 Pivotal Clinical Trials.
Stuart L. Silverman 3 , Andrew J. Holman 4 , Beverly Benson 1 , Sarah
Alvarez-Horine 1 , Y. Grace Wang 1 and Piercarlo Sarzi-Puttini 2 ,
1
Jazz Pharmaceuticals, Inc., 2 L. Sacco University Hospital, Milano,
Italy, 3 Osteoporosis Medical Center, Beverly Hills, CA, 4 Pacific
Rheumatology Associates, Inc., Renton, WA.
816. SPECT Imaging of the Brain: Regional Cerebral Blood
Flow before and after Treatment of Patients with Primary
Fibromyalgia. Manal Osman 3 , Osama Hajji 3 , Ola Abdul Nasser 3 ,
Ahmad Khodair 2 and Nashwa Al Sarraf 1 , 1 Internal Medicine
Department, Faculty of Medicine, Cairo University, Cairo,
Egypt, 2 Radiology Department, Faculty of Medicine, Ain Shams
University, Cairo, Egypt, 3 Rheumatology and Rehabilitation
Department, Faculty of Medicine, Ain Shams University, Cairo,
Egypt.
817. The Prevalence of Fibromyalgia in Patients with Chronic
Hepatitis C Infection. Ausaf Mohammad 1 , John J. Carey 4 , Eoin
R. Storan 2 , Margaret Scarry 2 , Mary B. Keane 2 , Angela Moore 2 ,
Ann Lyons 2 , Maureen O’ Grady 2 , Catriona Minihan 2 and John M.
Lee 3 , 1 Department of Hepatology and Rheumatology, Galway
University Hospital, Ireland, 2 Galway University Hospital,
3
Hepatology Galway University Hospital, 4 Rheumatology Merlin
Park University Hospital.
818. The Prevalence of Fibromyalgia in Patients with Hereditary
Hemochromatosis. Ausaf Mohammad 1 , John J. Carey 4 , Eoin R.
Storan 2 , Margaret Scarry 2 , Mary B. Keane 2 , Angela Moore 2 , Ann
Lyons 2 , Maureen O’ Grady 2 , Catriona Minihan 2 and John M.
Lee 3 , 1 Department of Hepatology and Rheumatology Galway
University Hospital, Ireland, 2 Galway University Hospital,
3
Hepatology Galway University Hospital, 4 Rheumatology Merlin
Park University Hospital.
819. Use of Path Analysis To Evaluate the Effects of Sodium Oxybate
on Pain Reduction in Patients with Fibromyalgia. Fowzia
Ibrahim 2 , Chinglin Lai 1 and Ernest Choy 3 , 1 Jazz Pharmaceuticals,
Inc., 2 King’s College London, 3 Kings College Hospital, London,
United Kingdom.
820. Very Low Dosage (VLD) Bedtime Cyclobenzaprine (CBP)
Reduces Cyclic Alternating Pattern (CAP) Rate Indices of
EEG Sleep Instability and Improves Pre-Sleep Fatigue in
Fibromyalgia Syndrome (FMS). Harvey Moldofsky 1 , Herbert W.
Harris 2 , Tad Archambault 4 , Terence Kwong 1 and Seth Lederman 3 ,
1
Centre for Sleep & Chronobiology, Toronto, ON, Canada, 2 Krele
Pharmaceuticals, Saddle Brook, NJ, 3 Krele Pharmaceuticals, New
York, NY, 4 VirtuStat Ltd, North Wales, PA.
821. Vibrotactile Analgesia Is Not Abnormal in Fibromyalgia
Patients. Casey T. Goldman 2 , Donald D. Price 2 , Michael
E. Robinson 2 and Roland Staud 1 , 1 Univ of Florida JHMHC,
Gainesville, FL, 2 University of Florida.
Genetics, Genomics and Proteomics in the Rheumatic Diseases
822. A Putative Functional Variant within the Ubiquitin-Associated
Domain-Containing Protein 2 Gene (UBAC2) Is Associated
with Increased Risk of Behcet’s Disease. Amr H. Sawalha 7 ,
Travis Hughes 6 , Ajay Nadig 6 , Vuslat Yilmaz 2 , Kenan Aksu 1 ,
Gokhan Keser 1 , Ayse Cefle 3 , Ayten Yazici 3 , Andac Ergen 5 , Haner
Direskeneli 4 and Güher Saruhan-Direskeneli 2 , 1 Ege University,
2
Istanbul University, 3 Kocaeli University, 4 Marmara University,
Istanbul, Turkey, 5 Okmeydani Research and Education Hospital,
6
OMRF, 7 University of Oklahoma, OMRF, VAMC, Oklahoma City,
OK.
823. A Role for PACE4 in Pain in Mice and Humans: Pain Phenotype
of a PACE4 Null Mutant and Genetic Association with
Knee Osteoarthritis Pain. Anne-Marie M. Malfait 6 , Albert B.
Seymour 5 , Ana M. Valdes 4 , Linda S. Wood 5 , Kathryn Durham 5 ,
Micky Tortorella 3 , Nigel K. Arden 8 , Frances L. Vaughn 7 , Paul
E. Leaverton 7 , Deborah J. Hart 4 , Robert E. Sorge 1 , Susana
G. Sotocinal 2 , Ara Schorscher-Petcu 1 and Jeffrey S. Mogil 1 ,
1
Dept of Psychology and Alan Edwards Centre for Research
on Pain, McGill University, Montreal, QC, Canada, 2 Dept of
Psychology and Alan Edwards Centre for Research on Pain,
McGill University, 3 Guangzhou Institute of Biomedical Health,
Guangzhou, China, 4 King’s College London, London, United
Kingdom, 5 Pfizer Global Research and Development, Cambridge,
MA, 6 Rush University Medical Center, Chicago, IL, 7 The Arthritis
Research Institute of America, Clearwater, FL, 8 University of
Oxford, Oxford, United Kingdom.
824. Analysis of the Influence of PTPN22 Gene Polymorphisms in
Systemic Sclerosis. Lina Marcela Diaz-Gallo 7 , Pravitt Gourh 27 ,
Jasper Broen 4 , Carmen Simeón 16 , Vicent Fonollosa 16 , Norberto
Ortego-Centeno 13 , M. C. Vonk 4 , Marieke Coenen 5 , Gabriela
Riemekasten 2 , Nicolas Hunzelmann 1 , Roger Hesselstrand 3 ,
Filemon K. Tan 26 , Sandeep K. Agarwal 26 , John D. Reveille 26 ,
Shervin Assassi 26 , Francisco J. García-Hernandez 17 , Patricia
Carreira 18 , Maria Teresa Camps 12 , Antomio Fernandez-Nebro 19 ,
Paloma Garcia de la Peña 23 , R. Rios 13 , T. Nearney 30 , D. Hilda 28 ,
Miguel Angel González-Gay 22 , Paolo Airo 25 , Lorenzo Beretta 8 ,
Raffaella Scorza 8 , Ariane Herrick 10 , Jane Worthington 9 , Ana
Pros 21 , Inmaculada Gómez-Gracia 24 , Luis Trapiella 15 , Gerard
Espinosa 14 , Ivan Castellvi 20 , Torsten Witte 6 , Filip De Keyser 29 ,
Marie Vanthuyne 11 , Maureen D. Mayes 26 , Timothy R. D.J.
Radstake 4 , Frank C. Arnett 26 , Javier Martin 7 and Blanca Rueda 7 ,
1
Department of Dermatology, University of Cologne, Germany,
2
Department of Rheumatology and Clinical Immunology, Charité
196
2010 Program Book